ASAH1 and tuberous sclerosis: Our data support the concept that the selectively increased expression of DEGS1 and ASAH1 in TSC tumor cells leads to increased sphingolipid biosynthesis, which in turn enhances TSC tumor cell viability and growth in preclinical models.